article thumbnail

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics

HCPLive

In this episode, hosts explore the latest updates to the ADA Standards of Care on therapeutic innovations and their real-world impact on diabetes management.

article thumbnail

The New Era of Continuous Glucose Monitoring (CGM) Expanding Access and Improving Outcomes

Cardiometabolic Health Congress

Recent over-the-counter (OTC) approvals for CGM systems are transforming diabetes management and lifestyle management for those without diabetes, making this an exciting time for healthcare professionals and their patients. Plus, understand the broader implications of these innovations for expanding access and advancing health equity.

article thumbnail

FDA Approves First Year-Long Continuous Glucose Monitoring Sensor for Diabetes

Cardiometabolic Health Congress

Developed by Senseonics and Ascensia Diabetes Care, the device represents a significant advancement in long-term glucose monitoring technology. The approval addresses several challenges faced by diabetes patients, including the inconvenience of frequent sensor changes, accidental dislodgement, and data interruptions.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

This fall, we come together for the largest and most innovative cardiometabolic event in honor of the legacy of Dr. George L. Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease.

Education 100
article thumbnail

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

DAIC

As Cleerly continues to develop cardiovascular innovations to support patients and healthcare professionals, we are honored to have received Breakthrough Device Designation and join the TAP Pilot,” said James K. Min , MD, Founder and CEO of Cleerly.

article thumbnail

FIRE1 Completes Enrollment in US Early Feasibility Study of Innovative Remote Heart Failure Monitoring System

DAIC

FIRE1 seeks to transform heart failure management by enabling patients to monitor and control their fluid volume themselves with a consumer-friendly device at home, similar to how continuous glucose monitoring transformed diabetes care. and is the most common cause of hospitalization for those aged 65 and over.

article thumbnail

Top 10 AI Cardiometabolic Startups to Watch in 2025 

Cardiometabolic Health Congress

These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. These companies are at the forefront of innovation, driving improvements in patient outcomes and reshaping the future of healthcare delivery.